HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Delayed graft function of cadaveric renal transplants is prevented by diltiazem.

AuthorsM Carmellini, M Salvadori, R Di Stefano, E Bertoni, G Nicita, A Rosati, G Taddei, P Rindi, G Rizzo, F Mosca
JournalTransplantation proceedings (Transplant Proc) Vol. 28 Issue 1 Pg. 80-2 (Feb 1996) ISSN: 0041-1345 [Print] United States
PMID8644348 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Calcium Channel Blockers
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Diltiazem
Topics
  • Adult
  • Cadaver
  • Calcium Channel Blockers (therapeutic use)
  • Diltiazem (therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Graft Rejection (therapy)
  • Graft Survival (drug effects)
  • Histocompatibility Testing
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Kidney Transplantation (physiology)
  • Male
  • Muromonab-CD3 (therapeutic use)
  • Retrospective Studies
  • Transplantation, Homologous
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: